Nagasaki Nagasaki, Japan
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Phase
3Span
192 weeksSponsor
Janssen Research & Development, LLCPalos Hills, Illinois
Recruiting
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1- Mediated Proteinuric Kidney Disease
Phase
2/3Span
222 weeksSponsor
Vertex Pharmaceuticals IncorporatedPalos Hills, Illinois
Recruiting
1-2 of 2